Dry powder inhalers: The influence of device resistance and powder formulation on drug and lactose deposition in vitro
- 22 December 1998
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 7 (1) , 73-80
- https://doi.org/10.1016/s0928-0987(98)00008-6
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers Part 1. Inhalation characteristics, work of breathing and volunteers' preference in dependence of the inhaler resistanceInternational Journal of Pharmaceutics, 1996
- In vitro tolerability of human nasal mucosa: histopathological and scanning electron-microscopic evaluation of nasal forms containing Sandostatin®Cell Biology and Toxicology, 1995
- Determination of the minimum dose of lactose drug carrier that can be sensed during inhalation.British Journal of Clinical Pharmacology, 1995
- In Vitro Testing of Dry Powder InhalersAerosol Science and Technology, 1995
- The Relationship Between Powder Inhaler Resistance and Peak Inspiratory Conditions in Healthy Volunteers — Implications for In Vitro TestingJournal of Aerosol Medicine, 1993